BioSpace News Archive

According to Transparency Market Research’s latest market report on the wound closure strips market for the historical period of 2017–2018 and forecast of 2019–2027, prevalence of wounds and diseases

There are several factors that are responsible for the overall development of the global polymerase chain reaction market.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter and six-months ended June 30, 2020, after the market close, and host a conference call at 4:30 pm Eastern Time on Tuesday, August 4.

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2020.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will participate in two upcoming investor conferences.

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2020.

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock, in an underwritten public offering

NetNoggin®, a premier market research agency that specializes in the pharmaceutical industry, has announced the release of its newest research report, NetNog: #genesis® Cystic Fibrosis V2.0 with updates due to TRIKAFTA.

Research led by the Children’s Oncology Group (COG) and NRG Oncology, and supported by the St. Baldrick’s Foundation, discovered that adding pazopanib, a type of chemotherapy, to preoperative chemoradiotherapy improves response to treatment for soft tissue sarcoma patients, compared with chemoradiotherapy alone

Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming virtual investor conferences